Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first
approved by the US Food and Drug Administration in 2012. Despite correlations of …

Reducing HIV-related stigma may enhance the quality of HIV prevention and care services
and is a national prevention goal. The objective of this systematic review was to identify …

Background: HIV infection is a persistent health concern in the United States, and men who
have sex with men (MSM) continue to be the most affected population. Objective: To …

The potential for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) to
reduce the racial disparities in HIV incidence in the United States might be limited by racial …

Introduction: Despite documented effectiveness of pre-exposure prophylaxis (PrEP), PrEP
uptake remains low among men who have sex with men (MSM), the population bearing the …

Abstract Purpose of Review Pre-exposure prophylaxis (PrEP) is a potent HIV prevention
strategy, but uptake of daily oral PrEP remains low. This review covers PrEP agents currently …

Introduction Improving the delivery of existing evidence‐based interventions to prevent and
diagnose HIV is key to Ending the HIV Epidemic in the United States. Structural barriers in …

Although diagnoses of human immunodeficiency virus (HIV) infection in women have been
decreasing over the past several years, women still comprise nearly 20% of all HIV …

Background In 2015, there were approximately 40,000 new HIV diagnoses in the United
States. Pre-exposure prophylaxis (PrEP) is an effective strategy that reduces the risk of HIV …

Background Black women are disproportionately affected by the HIV epidemic. Strategies to
increase Black women's use of pre-exposure prophylaxis (PrEP) are needed. Methods …